OUR SCIENTIFIC ADVISORY BOARDS

Contributing to Signant's forward-looking strategy

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at  www.signanthealth.com.

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models.

For more than 25 years, Signant solutions have been trusted by over 600 sponsors and CROs of all sizes – including all Top 20 pharma – for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at signanthealth.com.

Our Scientific Advisory Boards (SABs), including Psychiatry, Neurology, and Internal Medicine, advise on future directions of the clinical trials market – embracing technologies, new products and other innovative trends to assist in Signant’s forward-looking strategy. Each SAB is led by a Signant Coordinator and is comprised of scientific and clinical experts who have made significant contributions to advancing the field and are committed to Signant’s mission.

SAB Co-chair

Neurology & Alzheimer's Disease

Signant Health's Neurology and Alzheimer's Disease Scientific Advisory Board, composed of Key Opinion Leaders, plays a pivotal role in guiding Signant's strategic collaborations with sponsors. These advisors provide insights into current and future developments, uncover opportunities, and contribute to research and publications, showcasing Signant's value in supporting clinical trials that advance the development of new treatments for Alzheimer's disease and other neurological conditions.

Psychiatry

Scientific Advisory Board Lead, Signant Health

The Signant Health Psychiatric Scientific Advisory Board comprises internationally recognized and respected academic leaders in psychopharmacology research and treatment, novel therapeutics development, and innovative assessment technologies. Members collaborate closely with Signant Scientific Leadership to further the development of evidence-based practices for optimizing data quality and signal detection in psychiatric treatment research.

SAB Chair

Scientific Advisory Board Lead, Signant Health

Double-click to edit this text

Internal Medicine

Scientific Advisory Board Leads, Signant Health

Signant Health's Internal Medicine Science Advisory Board, comprising academic and global key opinion leaders, acts as a dynamic link between Signant's scientific teams and the pharmaceutical industry. Through active involvement in landmark clinical trials, they enhance collaboration, develop novel endpoints, and contribute to joint publications, advancing evidence-based practices in internal medicine research. 

50+ CLINICAL SCIENTISTS

Science is a core part of what we do.  In addition to our in-house Scientific Leadership and external Scientific Advisory Boards we have over 50 full-time clinical and eCOA experts who work closely with our customers in early study design, COA strategy, and optimal solution design for clinical trials and protocols. Working together with our Scientific Leadership and Scientific Advisory Board members, Signant provides unrivalled scientific input and consulting to ensure the best studies, best solutions and best implementation practices are in place to generate highest quality, reliable clinical evidence to support decision making by all stakeholders, including regulatory bodies.